• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Skip to investors navigation
Insmed

Insmed

Powered by Purpose

LinkedIn Twitter Contact Us Job Opportunities

  • Culture
    • Our Culture
      • Mission & Vision
      • Careers
      • Responsibility
        • Inclusion at Insmed
        • Grants & Funding
        • Global Healthcare Compliance

    Our Global Company

    Find available career opportunities in the U.S., Japan, or Europe.

    Find Jobs

  • Patients
    • Our Patients
      • Disease Areas
      • Resources
      • Patient Access

    Current Clinical Trials

    You may be eligible for one of our clinical trials.

    See if you may qualify

  • Science
    • Our Science
      • ARIKAYCE®
      • Our Research
      • Pipeline
      • Clinical Trials
      • Investigator-Initiated Research

    Our Research Team

    Working together to develop new medicines and technologies that have the potential to transform patients’ lives.

    Learn More

  • About
    • About Insmed
    • Management Team
    • Board of Directors
    • Partnerships
  • Investors
    • Investors
    • Events & Presentations
    • Stock Information
    • News Releases
    • SEC Filings
    • Annual Reports
    • Analyst Coverage
    • Corporate Governance
    • Email Alerts
    • Investor FAQs
Home / Investors/ News Releases

News Releases

Month Year
Su Mo Tu We Th Fr Sa
Month Year
Su Mo Tu We Th Fr Sa
Email Alerts
Advanced Search
  
Asset Types
           
 Basic Search
  • Aug 3, 2017
    Insmed Reports Second Quarter 2017 Financial Results and Provides Business Update
    On Track to Report Top-Line Results from Phase 3 CONVERT Study in September plus or minus one month
  • Jul 27, 2017
    Insmed to Host Second Quarter 2017 Financial Results Conference Call on Thursday, August 3, 2017
  • Jul 12, 2017
    Insmed to Host Analyst and Investor Day on July 19, 2017
  • Jun 13, 2017
    Insmed to Present at the JMP Securities Life Sciences Conference
  • Jun 8, 2017
    Insmed Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
  • May 15, 2017
    Insmed Announces Key Additions to its Executive Management Team
    Paolo Tombesi named as Chief Financial Officer
  • May 3, 2017
    Insmed Reports First Quarter 2017 Financial Results and Provides Business Update
    Advancing Toward Top-Line Results from CONVERT Study in 2H 2017
  • Apr 27, 2017
    Insmed to Present at the Deutsche Bank 42nd Annual Health Care Conference
  • Apr 26, 2017
    Insmed to Host First Quarter 2017 Financial Results Conference Call on Wednesday, May 3, 2017
  • Feb 28, 2017
    Insmed to Present at the Cowen and Company 37th Annual Health Care Conference
  • Feb 23, 2017
    Insmed Reports Fourth Quarter 2016 Financial Results and Provides Business Update
    On Track to Report Top-Line Results from CONVERT Study in 2H 2017
  • Feb 16, 2017
    Insmed to Host Fourth Quarter and Year-end 2016 Financial Results Conference Call on Thursday, February 23, 2017
  • Feb 14, 2017
    Insmed Inc. Extends ARIKAYCE Intellectual Property Protection with Issuance of New U.S. Patent
  • Jan 4, 2017
    Insmed to Present at the 35th Annual J.P. Morgan Healthcare Conference
  • Nov 14, 2016
    Insmed to Participate at November Investor Conferences
  • Nov 3, 2016
    Insmed Reports Third Quarter 2016 Financial Results and Provides Business Update
    Enrollment objective achieved in phase 3 CONVERT study
  • Oct 27, 2016
    Insmed to Host Third Quarter 2016 Financial Results Conference Call on Thursday, November 3, 2016
  • Oct 18, 2016
    Insmed Announces Publication of Phase 2 Study of ARIKAYCE in Treatment-Refractory Nontuberculous Mycobacterial Lung Disease
    Data in American Journal of Respiratory and Critical Care Medicine demonstrate ARIKAYCE's potential to achieve early and sustained negative sputum cultures
  • Oct 5, 2016
    Insmed Announces Worldwide License Agreement with AstraZeneca for Oral DPP1 Inhibitor
  • Sep 27, 2016
    Insmed Appoints Roger Adsett as Chief Commercial Officer
  • Sep 8, 2016
    Insmed to Participate at September Investor Conferences
  • Aug 31, 2016
    Insmed Announces Upcoming Presentations at European Respiratory Society 2016 International Congress
  • Aug 4, 2016
    Insmed Reports Second Quarter 2016 Financial Results
  • Jun 8, 2016
    Insmed Announces Withdrawal of Marketing Authorization Application for ARIKAYCE™ in Europe
  • May 9, 2016
    Insmed to Present at the Bank of America Global Healthcare Conference
  • May 5, 2016
    Insmed Reports First Quarter 2016 Financial Results
  • May 3, 2016
    Insmed Announces Upcoming Presentations at the American Thoracic Society 2016 International Meeting
  • Mar 2, 2016
    Insmed to Present at the 36th Annual Cowen & Company Healthcare Conference
  • Feb 25, 2016
    Insmed Reports Fourth Quarter 2015 Financial Results
  • Jan 5, 2016
    Insmed to Present at the 34th Annual J.P. Morgan Healthcare Conference
  • Nov 24, 2015
    Insmed to Present at the Piper Jaffray 27th Annual Healthcare Conference
  • Nov 11, 2015
    Insmed to Present at the Stifel 2015 Healthcare Conference
  • Nov 6, 2015
    Insmed Reports Third Quarter 2015 Financial Results and Provides Business Update
  • Oct 31, 2015
    Insmed to Host Third Quarter 2014 Financial Results Conference Call on Thursday, November 6, 2014
  • Oct 29, 2015
    Insmed to Host Third Quarter 2015 Financial Results Conference Call on Friday, November 6, 2015
  • Oct 26, 2015
    Insmed Announces Upcoming Data Presentation at AMCP Nexus 2015
  • Oct 19, 2015
    The Balancing Act(R) on Lifetime to Feature NTM Lung Disease
  • Oct 14, 2015
    INSMED Launches Comprehensive Educational Campaign to Raise Awareness of NTM Lung Disease
    NTMfacts.com Provides a Dynamic Resource for Healthcare Providers to Learn More About NTM Lung Disease Through Patient Testimonials and Case Studies
  • Oct 6, 2015
    Insmed Announces Upcoming Data Presentations at Infectious Disease Week 2015
  • Sep 22, 2015
    Insmed Announces Upcoming Data Presentations at ERS 2015
  • Sep 14, 2015
    Insmed Announces Upcoming Data Presentations at ICAAC/ICC 2015
  • Sep 5, 2015
    Insmed to Present at the Rodman & Renshaw Annual Global Investment Conference
  • Sep 3, 2015
    Insmed to Present at the Leerink Partners Rare Disease Roundtable
  • Aug 11, 2015
    Insmed Announces Proposed Public Offering of Common Stock
  • Aug 6, 2015
    Insmed Reports Second Quarter 2015 Financial Results and Provides Business Update
  • Jul 28, 2015
    Insmed to Host Second Quarter 2015 Financial Results Conference Call on Thursday, August 6, 2015
  • Jun 17, 2015
    Insmed to Participate at the JMP Securities Life Sciences Conference
  • May 13, 2015
    Insmed Announces Upcoming Data Presentations at the American Thoracic Society 2015 International Meeting
  • May 11, 2015
    Insmed to Participate at the UBS Global Healthcare Conference
  • May 7, 2015
    Insmed Reports First Quarter 2015 Financial Results
Show 5102550100 per page
  • «
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • …
  • 13
  • »
Stay In The Loop

Want to stay up to date on our news, events, and filings? Set up your
email alerts.

Sign Up

View the latest Insmed Investor Presentation

Download

Primary Sidebar

Investor Menu

  • Investors
  • Events & Presentations
  • Stock Information
  • News Releases
  • SEC Filings
  • Annual Reports
  • Analyst Coverage
  • Corporate Governance
  • Email Alerts
  • Investor FAQs

Investor Menu

Footer

Insmed
LinkedIn Twitter

Contact Us

Job Opportunities

  • Our Culture
    • Mission & Vision
    • Careers
    • Responsibility
      • Inclusion at Insmed
      • Grants & Funding
      • Global Healthcare Compliance
  • Our Patients
    • Disease Areas
    • Resources
    • Patient Access
  • Our Science
    • ARIKAYCE®
    • Our Research
    • Pipeline
    • Clinical Trials
    • Investigator-Initiated Research
  • About
    • Management Team
    • Board of Directors
    • Partnerships
  • Investors
  • Events & Presentations
  • Stock Information
  • News Releases
  • SEC Filings
  • Annual Reports
  • Analyst Coverage
  • Corporate Governance
  • Email Alerts
  • Investor FAQs

© 2023 Insmed Incorporated. All Rights Reserved. Terms of Use Privacy Policy

Culture
Patients
Science
logo
  • Culture
    • Mission & Vision
    • Careers
    • Responsibility
      • Inclusion at Insmed
      • Grants & Funding
      • Global Healthcare Compliance
  • Patients
    • Disease Areas
    • Resources
    • Patient Access
  • Science
    • ARIKAYCE®
    • Our Research
    • Pipeline
    • Clinical Trials
    • Investigator-Initiated Research
  • About
    • Management Team
    • Board of Directors
    • Partnerships
  • Investors
    • Investors
    • Events & Presentations
    • Stock Information
    • News Releases
    • SEC Filings
    • Annual Reports
    • Analyst Coverage
    • Corporate Governance
    • Email Alerts
    • Investor FAQs

LinkedIn Twitter

Contact Us Job Opportunities

© 2023 Insmed Incorporated.
All Rights Reserved.

Terms of Use Privacy Policy